Grant: Doctoral Research Award: Canada Graduate Scholarships
University of Calgary
$105,000.00
Mining the untapped resource of population-based administrative healthcare data for celiac disease research: Defining the epidemiology and burden of celiac disease in Alberta
FY 2022-23
Summary
Celiac disease is an increasingly diagnosed autoimmune disorder throughout the industrialized world. It presents with diverse symptoms; therefore, it often takes years of poor health before receiving a diagnosis, placing significant burden both on individuals and healthcare systems.
Electronic medical records and healthcare data routinely collected for administrative purposes are increasingly used by researchers to better understand chronic conditions, improve public health, and reduce strain on healthcare systems. However, this resource has been underutilized in the study of celiac disease. Accordingly, this project investigates various databases in Alberta ranging from physician visits to laboratory records to identify recent markers of disease burden (prevalence, incidence, cost).
By studying health encounters, patterns suggestive of celiac disease are detected and used to estimate prevalence (i.e., how many are living with celiac disease in 2020) and incidence (i.e., how many new diagnoses of celiac disease in 2020). These outcomes can be validated through comparison of gold standard lab values and pathology reports. This research also identifies respective trends in healthcare utilization, such as emergency visits and drug prescriptions, before and after diagnosis. In turn, we learn how much this condition is costing the healthcare system through increased physician visits, laboratory testing, and other complications arising from disease progression. Finally, as celiac disease affects certain groups in different ways, this study enables an investigation of discrepancies in care across factors such as age, sex, and socioeconomic status.
Findings of this research are the first to define the prevalence of celiac disease in a Canadian setting and to measure the impact celiac disease has on the healthcare system. These research outputs then inform the optimal strategy for policy makers and healthcare providers to reduce the burden of celiac disease.
Department
Program
Doctoral Research Award: Canada Graduate Scholarships
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
475929
Name
King James
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Population and Public Health
Theme2
Health systems / services
Prcname2
Doctoral Research Awards - B
Projecttitle
Mining the untapped resource of population-based administrative healthcare data for celiac disease research: Defining the epidemiology and burden of celiac disease in Alberta
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Administrative Data; Biostatistics; Celiac Disease; Electronic Medical Records; Epidemiology; Population-Based
Abstract
Celiac disease is an increasingly diagnosed autoimmune disorder throughout the industrialized world. It presents with diverse symptoms; therefore, it often takes years of poor health before receiving a diagnosis, placing significant burden both on individuals and healthcare systems.
Electronic medical records and healthcare data routinely collected for administrative purposes are increasingly used by researchers to better understand chronic conditions, improve public health, and reduce strain on healthcare systems. However, this resource has been underutilized in the study of celiac disease. Accordingly, this project investigates various databases in Alberta ranging from physician visits to laboratory records to identify recent markers of disease burden (prevalence, incidence, cost).
By studying health encounters, patterns suggestive of celiac disease are detected and used to estimate prevalence (i.e., how many are living with celiac disease in 2020) and incidence (i.e., how many new diagnoses of celiac disease in 2020). These outcomes can be validated through comparison of gold standard lab values and pathology reports. This research also identifies respective trends in healthcare utilization, such as emergency visits and drug prescriptions, before and after diagnosis. In turn, we learn how much this condition is costing the healthcare system through increased physician visits, laboratory testing, and other complications arising from disease progression. Finally, as celiac disease affects certain groups in different ways, this study enables an investigation of discrepancies in care across factors such as age, sex, and socioeconomic status.
Findings of this research are the first to define the prevalence of celiac disease in a Canadian setting and to measure the impact celiac disease has on the healthcare system. These research outputs then inform the optimal strategy for policy makers and healthcare providers to reduce the burden of celiac disease.
Competitiondate
202211
Approvedterm2
3 yrs 0 mth
Pinamesdelim
King, James
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~